One FTSE 100 turnaround stock I’d buy and one I’d sell

Roland Head looks takes a bold view on two battered FTSE 100 (INDEXFTSE:UKX) stocks.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today I’m looking at two controversial and rather battered FTSE 100 stocks. I believe the outlook for each company may not be what you might expect, given recent news.

The first share under consideration is £32bn pharma group Shire (LSE: SHP). Chief executive Flemming Ornskov has never been short of ambition for his firm, and last year he went all out with a $32bn deal to acquire US firm Baxalta.

The benefits of this deal are now starting to appear. In its third-quarter results on Friday, the group reported a 20% increase in adjusted earnings, which rose to $3.81. This corresponded to a 20% increase in adjusted net profit, which rose to $1,158m.

Should you invest £1,000 in Marks and Spencer right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Marks and Spencer made the list?

See the 6 stocks

Highlights from the quarter included a 32% increase in sales of immunology medicines, compared to the same period last year. This helped to offset the effects of weaker demand for genetic treatments.

Improving financials

The group’s financial performance has certainly improved this year. Net cash generated by operating activities doubled to $1,055m during the quarter, helping Shire to reduce its net debt by a further $920m.

With nine months of the year complete, management has left its guidance for the full year unchanged. Based on broker forecasts, this suggests that the stock trades on a forecast P/E of 9.3 for 2017.

This may seem cheap, but it’s worth remembering that the group’s net debt of $20.4bn makes the stock significantly more expensive than the P/E ratio suggests.

An alternative valuation measure I like to use is earnings yield, which compares operating profit with enterprise value (market cap plus net debt). I estimate Shire’s earnings yield at about 3.5%, but I normally prefer to invest in stocks with an earnings yield of at least 8%.

In my view, it’s probably too soon to check back into Shire.

Shopping for a bargain?

High street stalwart Marks and Spencer Group (LSE: MKS) is seriously out of fashion at the moment. But the group’s food business is growing steadily, and selling clothes still generates a lot of cash.

Indeed, the group’s shares currently trade on a trailing price/free cash flow ratio of just 8.6, which is very cheap if it’s sustainable. The evidence so far is that this cash generation can be sustained.

Indeed, the firm’s adjusted earnings are expected to bottom out at 27.9p per share this year, before climbing to 28.5p in 2018/19. This puts the stock on a reasonable forecast P/E of 12.4. It also provides a decent level of cover for the expected dividend payout of 18.7p per share, which implies a yield of 5.4% at the share price of 345p.

I’m starting to be get interested in M&S, as I think the group’s Food business should continue to offset a slower recovery in the clothing and home divisions. The first-quarter figures published in the summer seem to support this view — Clothing & Home revenue fell by 0.5%, but Food sales rose by 4.5%.

The business is being reshaped to provide more space for Simply Food, and to improve the stores’ integration with the group’s online sales channels. This seems logical to me and although it’s too soon to be certain, I believe now might be a good time to buy into the turnaround.

Like buying £1 for 31p

This seems ridiculous, but we almost never see shares looking this cheap. Yet this Share Advisor pick has a price/book ratio of 0.31. In plain English, this means that investors effectively get in on a business that holds £1 of assets for every 31p they invest!

Of course, this is the stock market where money is always at risk — these valuations can change and there are no guarantees. But some risks are a LOT more interesting than others, and at The Motley Fool we believe this company is amongst them.

What’s more, it currently boasts a stellar dividend yield of around 10%, and right now it’s possible for investors to jump aboard at near-historic lows. Want to get the name for yourself?

See the full investment case

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Roland Head has no position in any of the shares mentioned. The Motley Fool UK has recommended Shire. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Income of almost 12%! 3 stunning FTSE dividend stocks now have double-digit yields

Harvey Jones is amazed by the sky-high income on offer from these FTSE 100 dividend stocks, but he's also aware…

Read more »

Investing Articles

As vehicle sales slump, should I buy Tesla stock on the dip?

Andrew Mackie assesses whether Elon Musk’s political leanings are destroying the Tesla brand or is now the time to be…

Read more »

Dividend Shares

Why this stock market correction is great for passive income investors

Jon Smith explains why those looking for passive income from dividends could benefit from the move lower in stock prices…

Read more »

Investing Articles

The FTSE’s tanking. Here’s what I’m doing

In the blink of an eye, the FTSE has fallen more than 10% due to economic uncertainty. Here’s how Edward…

Read more »

US Stock

Apple stock is close to 52-week lows. Should I snap it up now?

Jon Smith discusses the double-digit percentage fall in Apple stock last week and weighs up whether now's the time to…

Read more »

Investing For Beginners

2 FTSE 100 gems that rallied last week as the stock market tumbled

Jon Smith flags up a couple of FTSE 100 shares that actually jumped at a time when most of the…

Read more »

Investing Articles

Glencore’s share price is 53% off its 52-week highs. Is it time to consider buying?

Glencore’s share price has tanked due to concerns over an economic slowdown. Is this an amazing buying opportunity for long-term…

Read more »

Investing Articles

Forecast: in 1 year, the Marks and Spencer share price could be…

The Marks and Spencer share price has hit its highest point since 2016 after more than doubling under the new…

Read more »